EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Type XII collagen is elevated in serum from patients with solid tumors: a non-invasive biomarker of activated fibroblasts

Marina Crespo-Bravo, Annika Hettich, Jeppe Thorlacius-Ussing, Thomas R Cox, Morten A Karsdal, Nicholas Willumsen

Clinical and Experimental Medicine · 24.07.2024 · 24 (1)

DOI: 10.1007/s10238-024-01431-y ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Experimental Medicine, online erschienen am 24.07.2024. Verfasst von Marina Crespo-Bravo und 5 weiteren Autor:innen. Beteiligte Einrichtung: Nordic Bioscience A/S, 2730, Herlev, Denmark. mcb@nordicbio.com. Hauptthemen laut MEDLINE: Neoplasms, Biomarkers, Tumor, Enzyme-Linked Immunosorbent Assay, Collagen Type XII. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Danish Research Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Understanding the tumor microenvironment (TME) and extracellular matrix (ECM) is crucial in cancer research due to their impact on tumor progression. Collagens, major ECM components, regulate cell signaling and behavior. Of the 28 reported collagens, type XII collagen is known to be vital for ECM organization. Over-produced by cancer-associated fibroblasts (CAFs), its upregulation correlates with poor survival in various cancers. This study aimed to develop an ELISA for quantifying circulating type XII collagen as a cancer biomarker. A specific ELISA targeting the C-terminal of type XII collagen was developed and used to analyze serum samples from cancer patients ( n = 203) and healthy controls ( n = 33). Additionally, type XII collagen expression was assessed in CAFs and normal fibroblasts (NFs) from different tissues, both under TGF-β stimulated and non-stimulated conditions. The nordicPRO-C12 ELISA demonstrated robustness and specificity for type XII collagen. PRO-C12 levels were significantly elevated in patients with various cancers compared to healthy controls and effectively distinguished between cancer patients and controls. Findings were validated using gene expression data. Furthermore, Western blot analysis revealed increased type XII collagen expression in both CAFs and NFs upon TGF-β1 stimulation, suggesting a potential role of TGF-β1 in modulating the expression of type XII collagen in cancerous and normal tissue microenvironments. This study unveils a promising avenue for harnessing PRO-C12 as a non-invasive serum biomarker, enabling the quantification of type XII collagen fragments in cancer patients. Further investigations are warranted to explore the potential of PRO-C12 across different cancer types and disease stages, shedding light on its multifaceted role in cancer development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsBiomarkers, TumorEnzyme-Linked Immunosorbent AssayCollagen Type XIIHumansFemaleMaleTumor MicroenvironmentMiddle AgedFibroblastsCancer-Associated FibroblastsTransforming Growth Factor beta1AdultAged

Stichwörter der Autor:innen

CAFsECMFACITsMetastasisNon-invasive biomarkerType XII collagen

Substanzen

Biomarkers, TumorCollagen Type XIITransforming Growth Factor beta1

Autor:innen und Institutionen

  • Nordic Bioscience A/S, 2730, Herlev, Denmark. mcb@nordicbio.com.
  • Department of Biomedical Sciences, University of Copenhagen, 2200, Copenhagen, Denmark. mcb@nordicbio.com.
  • Nordic Bioscience A/S, 2730, Herlev, Denmark.
  • Department of Biomedical Sciences, University of Copenhagen, 2200, Copenhagen, Denmark.
  • Matrix and Metastasis Lab, Cancer Ecosystems Program, Garvan Institute of Medical Research and The Kinghorn Cancer Centre, Darlinghurst, NSW, Australia.
  • School of Clinical Medicine, UNSW Medicine & Health, UNSW Sydney, Sydney, NSW, Australia.

Förderung

  • Danish Research Foundation

Zitieren

APA

Crespo-Bravo, M., Hettich, A., Thorlacius-Ussing, J., Cox, T. R., Karsdal, M. A., & Willumsen, N. (2024). Type XII collagen is elevated in serum from patients with solid tumors: a non-invasive biomarker of activated fibroblasts. Clinical and Experimental Medicine, 24(1). https://doi.org/10.1007/s10238-024-01431-y

Vancouver

Crespo-Bravo M, Hettich A, Thorlacius-Ussing J, Cox TR, Karsdal MA, Willumsen N. Type XII collagen is elevated in serum from patients with solid tumors: a non-invasive biomarker of activated fibroblasts. Clinical and Experimental Medicine. 2024;24(1). doi:10.1007/s10238-024-01431-y

BibTeX
@article{CrespoBravo2024,
  author = {Crespo-Bravo, Marina and Hettich, Annika and Thorlacius-Ussing, Jeppe and Cox, Thomas R and Karsdal, Morten A and Willumsen, Nicholas},
  title = {Type XII collagen is elevated in serum from patients with solid tumors: a non-invasive biomarker of activated fibroblasts},
  journal = {Clinical and Experimental Medicine},
  year = {2024},
  volume = {24},
  number = {1},
  doi = {10.1007/s10238-024-01431-y}
}
Kostenlos starten →